Assessing Quality of Life Post-Breast Reconstruction Surgery: Findings from an Interim Analysis of the REKO 001 Three-Arm Clinical Trial with a Decade of Follow-Up - Summary - MDSpire
Advertisement
Assessing Quality of Life Post-Breast Reconstruction Surgery: Findings from an Interim Analysis of the REKO 001 Three-Arm Clinical Trial with a Decade of Follow-Up
To evaluate health-related quality of life (HRQoL) specifically in breast cancer patients post-surgery undergoing different surgical procedures over a long-term follow-up.
Key Findings:
Patients undergoing DIEP/FCI reconstruction reported improved quality of life at 5 months post-surgery despite higher complication rates (p-value needed).
Significant differences in age and previous surgeries were noted among the groups, with the mastectomy group being older (specific statistics needed).
A total of 204 questionnaires were returned at the 5-month follow-up (T2), with a loss of 30 patients from initial enrollment.
Interpretation:
The findings suggest that while DIEP/FCI reconstruction has a higher complication rate, it may lead to better HRQoL outcomes compared to mastectomy and implant-based reconstruction, influencing surgical decision-making.
Limitations:
The study is limited by its single-center design and potential biases in patient selection, which may affect the results.
A significant loss to follow-up may affect the generalizability of the results, necessitating caution in interpretation.
Conclusion:
The interim analysis indicates that autologous reconstruction can enhance quality of life shortly after surgery, providing valuable insights for surgical decision-making in breast cancer treatment and highlighting areas for future research.
